Publications by authors named "M C DiPasquale"

Article Synopsis
  • Recent research has evaluated inflammation-related and nutritional factors to create prognostic scores for non-small-cell lung cancer (NSCLC) patients undergoing immune checkpoint inhibitors (ICIs).
  • The study analyzed 191 advanced NSCLC patients, examining how pretreatment scores (ALI, LIPI, PNI, SIS) correlated with overall survival using statistical models.
  • Findings indicated that higher ALI, LIPI, PNI, and SIS scores were associated with significantly longer survival, crossing treatment types, highlighting their potential as prognostic tools for managing metastatic lung cancer.
View Article and Find Full Text PDF

Estrogen receptor (ER)-positive breast cancer (BC) is the most common BC subtype. Endocrine therapy (ET) targeting ER signaling still remains the mainstay treatment option for hormone receptor (HR)-positive BC either in the early or in advanced setting, including different strategies, such as the suppression of estrogen production or directly blocking the ER pathway through SERMs-selective estrogen receptor modulators-or SERDs-selective estrogen receptor degraders. Nevertheless, the development of de novo or acquired endocrine resistance still remains challenging for oncologists.

View Article and Find Full Text PDF

Take your vitamins, or don't? Vitamin E is one of the few lipophilic vitamins in the human diet and is considered an essential nutrient. Over the years it has proven to be a powerful antioxidant and is commercially used as such, but this association is far from linear in physiology. It is increasingly more likely that vitamin E has multiple legitimate biological roles.

View Article and Find Full Text PDF
Article Synopsis
  • Endocrine therapy (ET) is a primary treatment for estrogen receptor-positive breast cancer, using tools like aromatase inhibitors and medications such as tamoxifen to block estrogen signaling.
  • Resistance to ET, either from the start or after treatment, is a major reason for therapy failure and cancer progression, largely due to changes in the ESR1 gene.
  • New oral selective estrogen receptor degraders are being developed that can effectively target and overcome these resistance issues by reducing ER protein levels and blocking estrogen's effects, offering hope for better treatment outcomes.
View Article and Find Full Text PDF

Cellular membranes are responsible for absorbing the effects of external perturbants for the cell's survival. Such perturbants include small ubiquitous molecules like -alcohols which were observed to exhibit anesthetic capabilities, with this effect tapering off at a cut-off alcohol chain length. To explain this cut-off effect and complement prior biochemical studies, we investigated a series of -alcohols (with carbon lengths 2-18) and their impact on several bilayer properties, including lipid flip-flop, intervesicular exchange, diffusion, membrane bending rigidity and more.

View Article and Find Full Text PDF